Cargando…
The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
Despite enormous advances being made in diagnosis and therapeutic interventions, pancreatic ductal adenocarcinoma (PDAC) is still recognized as one of the most lethal malignancies. Early diagnosis and timely curative surgery can markedly improve the prognosis; hence, there is an unmet necessity to e...
Autores principales: | Gao, Zhuqing, Jiang, Wei, Zhang, Shutian, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754866/ https://www.ncbi.nlm.nih.gov/pubmed/31583198 http://dx.doi.org/10.1155/2019/9419072 |
Ejemplares similares
-
MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
por: Prinz, Christian, et al.
Publicado: (2022) -
Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
por: Mortoglou, Maria, et al.
Publicado: (2021) -
Nickel’s Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs
por: Mortoglou, Maria, et al.
Publicado: (2022) -
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2018) -
Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
por: Bauer, Andrea S., et al.
Publicado: (2012)